Clinical Trials on Intention to Get SARS-CoV-2 Antibody Test in South Africa
Total 37 results
-
Alvea Holdings, LLCCompletedSars-CoV-2 InfectionSouth Africa
-
BioNTech SECompletedCOVID-19 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS (Disease)United States, Germany, Turkey, South Africa
-
Shabir MadhiRecruitingCOVID-19 | SARS-CoV2 InfectionSouth Africa
-
Wits Health Consortium (Pty) LtdFred Hutchinson Cancer Center; Janssen Vaccines & Prevention B.V.; Right to Care and other collaboratorsRecruitingSARS CoV 2 InfectionSouth Africa
-
Desmond Tutu HIV FoundationAmsterdam Institute for Global Health and Development; University of Cape Town and other collaboratorsCompletedCovid19 | Sars-CoV-2 InfectionSouth Africa
-
South African National Blood ServiceUnknownTherapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19COVID-19 | SARS-CoV-2 Infection | Severe Acute Respiratory Syndrome Coronavirus 2South Africa
-
NovavaxBill and Melinda Gates FoundationCompletedCOVID-19 | SARS-CoV-2 InfectionSouth Africa
-
University of MelbourneThe George Institute; The University of Queensland; The Peter Doherty Institute... and other collaboratorsRecruitingSARS-CoV-2 Infection (COVID-19)Australia
-
National Institute for Communicable Diseases, South...Centers for Disease Control and Prevention; Fogarty International Center of... and other collaboratorsActive, not recruitingInfluenza | SARS-CoV-2 Infection | Respiratory Syncytial Virus (RSV)South Africa
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV2 InfectionUnited States, Puerto Rico
-
NovavaxCompleted
-
Gilead SciencesApproved for marketingSARS-CoV2 InfectionUnited States, Israel, Belgium, Spain, Australia, Denmark, Italy, Germany, France, Portugal, United Kingdom, Poland, Switzerland, Canada, Austria, Cyprus, Czechia, Estonia, Greece, Hungary, Iceland, Ireland, Lithuania, Netherlands, Romania and more
-
Leidos Life SciencesUnited States Department of DefenseTerminatedCOVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV InfectionUnited States
-
Prisma Health-UpstateCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States
-
NovavaxCompletedCOVID-19 | SARS CoV 2 InfectionAustralia
-
ACM BiolabsCompletedSARS-CoV-2 InfectionAustralia
-
Technovalia, Pty LtdChulalongkorn University; Southern Star Research Pty Ltd.; BioNet-AsiaActive, not recruitingCOVID-19, SARS CoV 2 InfectionAustralia
-
University of MelbourneLondon School of Hygiene and Tropical Medicine; The Alfred; University of Adelaide and other collaboratorsRecruitingInfluenza, Human | SARS-CoV-2 InfectionAustralia
-
AstraZenecaActive, not recruitingCOVID-19 | SARS-CoV-2 InfectionUnited States
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Germany, Turkey, South Africa, Argentina, Brazil
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Brazil, South Africa, Germany, Canada, Israel
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 Infection | Maternal ImmunizationUnited States, United Kingdom, Spain, Brazil, South Africa
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV-2 InfectionUnited States
-
PfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
COVID-19 Prevention NetworkNational Institute of Allergy and Infectious Diseases (NIAID); Medical Research...Active, not recruitingHIV Infections | COVID-19 | SARS-CoV-2 InfectionUganda, Malawi, South Africa, Botswana, Zambia, Kenya, Swaziland
-
BioNTech SEPfizerActive, not recruitingCOVID-19 | SARS-CoV-2 InfectionUnited States
-
MediMergent, LLCTerminatedSARS-CoV-2 InfectionUnited States
-
PfizerCompleted
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)Active, not recruitingA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
Regeneron PharmaceuticalsCompletedHealthy ParticipantsUnited States, Moldova, Republic of, Romania
-
National Institute of Allergy and Infectious Diseases...CompletedSARS-CoV-2 InfectionUnited States
-
BioNTech SEPfizerCompletedSARS-CoV-2 Infection, COVID-19United States, Spain, Finland, Poland, Mexico, Brazil
-
ShionogiRecruitingSARS-CoV-2 InfectionJapan, United States
-
Sean CollinsNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedCOVID-19 | Coronavirus Infection | SARS-CoV-2 InfectionUnited States
-
Sanford HealthNational Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaboratorsRecruitingMitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditionsUnited States, Australia